Research map: Beyond vascular endothelial growth factor: synergistic diagnostic value of multiple biomarkers in malignant pleural effusion. A cross-sectional analytical study

Back to the article

Papers in this map

  1. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? · Teizo Yoshimura · 2018 · 275 citations · Cited by this paper
  2. Growth differentiation factor-15 as a predictor of acute myocardial infarction: a multivariable modeling approach · 2025 · Related
  3. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1 · Jamie L. McClellan · 2012 · 114 citations · Cited by this paper
  4. Return to work and cardiovascular disease: functional capacity assessment, evidence and limits of applicability and the role of cardio-rehabilitation in occupational medicine · 2025 · Related
  5. The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process · Giovanni Barillari · 2020 · 105 citations · Cited by this paper
  6. Clinical spectrum and profile of interstitial lung disease: an ambispective study from a tertiary center in North India · 2026 · Related
  7. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis · Shayan Kassirian · 2022 · 104 citations · Cited by this paper
  8. Impact of smoking on obstructive sleep apnea: a retrospective study · 2026 · Related
  9. The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review) · Yao Chen · 2018 · 86 citations · Cited by this paper
  10. Physical activity levels and influencing factors in individuals with bronchiectasis: a cross-sectional study · 2026 · Related
  11. Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis · Yuan Yang · 2017 · 77 citations · Cited by this paper
  12. Lung autopsy findings in 44 COVID-19 deceased patients:pathological and radiological insights · 2026 · Related
  13. Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review · Man Zhang · 2021 · 59 citations · Cited by this paper
  14. Exploring the periodontal health status and level of matrix metalloproteinases in patients with interstitial lung disease: a case control study · 2026 · Related
  15. Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis · Yongchun Shen · 2012 · 33 citations · Cited by this paper
  16. Frequency of Aspergillus fumigatus sensitization and its impact on longitudinal asthma control: a 12-week prospective cohort study · 2026 · Related
  17. Systematic review and meta‐analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions · Eleftheria Fafliora · 2016 · 32 citations · Cited by this paper
  18. The Italian Community-based Pulmonology Manifesto: a national survey exploring the current state, critical issues, and perspectives for a national reference model · 2026 · Related
  19. Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion · Heung Yong Jin · 2003 · 29 citations · Cited by this paper
  20. Sarcopenia and osteoporosis in tobacco- and non-tobacco-exposure-related chronic obstructive pulmonary disease · 2026 · Related
  21. Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis · Peng Peng · 2022 · 26 citations · Cited by this paper
  22. Malignant Pleural Effusions—A Review of Current Guidelines and Practices · Prarthna Chandar Kulandaisamy · 2021 · 24 citations · Cited by this paper
  23. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin · Alfonso Fiorelli · 2016 · 18 citations · Cited by this paper
  24. Efferocytosis fuels malignant pleural effusion through TIMP1 · Lilan Zhao · 2021 · 15 citations · Cited by this paper
  25. Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion · Da‐Wei Wu · 2017 · 12 citations · Cited by this paper
  26. The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model · Jingyuan Wang · 2023 · 9 citations · Cited by this paper
  27. Managing complications of pleural procedures · John Gordon Williams · 2021 · 8 citations · Cited by this paper
  28. A potential role for VEGF in the diagnostic approach of pleural effusions · Aggeliki Psatha · 2016 · 7 citations · Cited by this paper
  29. Relations between serum and pleural fluid biomarkers: a new look of an old concept · Sabah Ahmed · 2020 · 3 citations · Cited by this paper
  30. Tumor marker assessment in cytologically negative pleural effusions from lung cancer by Machine Learning-based approach · Stefano Elia · 2018 · 1 citation · Cited by this paper
  31. Thematic series: Novel insights in pleural diseases · Μarios E. Froudarakis · 2019 · 1 citation · Cited by this paper
  32. The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion · Fatih Tekin · 2021 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)